Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 198
Selected: 0
NCT IDTitle
NCT03666351Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
NCT01442987Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia
NCT02302443A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470
NCT06724016Dose Escalation and Expansion Study of HM16390 in Advanced or Metastatic Solid Tumors
NCT04084184A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects
NCT00954304Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet
NCT06357910A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
NCT03897868A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
NCT04830449Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
NCT04084197A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects.
NCT04764201The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers
NCT05450575An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet
NCT02941731Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions
NCT02127320Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe
NCT00973115Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia
NCT06518122A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers
NCT04505436Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
NCT05548387A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers
NCT01872182Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
NCT04788290An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol
NCT02529800Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers
NCT01929512Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg
NCT01463982Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies
NCT01765478Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers
NCT02899455Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia
NCT01640535Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
NCT01197001A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
NCT03770728Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea
NCT01197014A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
NCT06595004A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients
NCT01869985Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers
NCT02552667Efficacy and Safety of HCP1102 Capsule
NCT02057172Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
NCT04325620Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease
NCT02294539Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
NCT02075281Effect of LAPS-Exendin on Body Weight in Obese Population
NCT01688193Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
NCT05191563A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.
NCT04039724Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers
NCT04252963Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)
NCT04081857A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects
NCT04654702Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.
NCT01819428NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma
NCT01452451Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
NCT03330327Molar Potency Study of HM12470 in Healthy Subjects
NCT03684642Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
NCT05598151Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
NCT01491217A Study of Oraxol® in Gastric Cancer Patients
NCT02418689Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens
NCT04510415Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI